entertainment -WSS

entertainment

author：focus 2025-10-01 18:45:26 - browse：8

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： ‘Oppenheimer’ and the risks of AI in health care

WSS

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

New safety details link Apellis eye drug to rare cases of blindness

Physician groups backed by private equity giant lobby on mergers

Amazon expands telehealth clinic nationwide

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Affordable Connectivity Program vital to health care, experts say

Wikipedia

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Walensky prepares to leave CDC — and Congress — behind

Study identifies new proteins linked to dementia risk 25 years later

In Memoriam: Notable people who died in 2023

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Trump demands the U.S. pay no more for drugs than other countries … again

Ending racial health disparities hinges on penalties, political will

Psychedelics group wrestles with new pharma identity

Driven by the pandemic, applicants flood public health schools

Medical leaders decry Supreme Court decision on affirmative action

Hospitals struggle to profit from CAR

hotspot

‘Oppenheimer’ and the risks of AI in health care

Amazon expands telehealth clinic nationwide

Amazon expands telehealth clinic nationwide

EQRx, failed developer of low

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Why Congress must ban federal programs from using QALYs

hotspot

focus

hotspot

hotspot